Osaka, Japan

Masatoshi Oshita


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2015-2016

Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Masatoshi Oshita: Pioneering Innovations in Influenza Antibodies**

Introduction

Masatoshi Oshita, an accomplished inventor located in Osaka, Japan, has made significant contributions to the field of immunology, particularly in the development of human antibodies against influenza viruses. With two patented innovations to his name, his work has the potential to enhance therapeutic interventions for influenza infections, improving global public health outcomes.

Latest Patents

Oshita's most recent patents focus on a human anti-human influenza virus antibody, which possesses a unique neutralization activity against human influenza viruses. Specifically, this antibody targets a highly conserved region in human influenza A virus subtype H3N2 and human influenza B virus, demonstrating efficacy in neutralizing these viruses. The antibody recognizes and binds to the hemagglutinin HA1 region of the influenza A virus subtype H3N2, contributing to its potential as a therapeutic agent. Notably, the patent also describes the DNA encoding the variable region of the antibody, providing detailed sequences that can be utilized in further research and development.

Career Highlights

Throughout his career, Oshita has been associated with esteemed institutions such as Osaka University and The Research Foundation for Microbial Diseases of Osaka University. His dedication to research and development in microbiology and immunology has positioned him as a key figure in advancing our understanding of viral infections and potential treatments.

Collaborations

Masatoshi Oshita has collaborated with notable peers in his field, including Kazuyoshi Ikuta and Ritsuko Koketsu. These collaborations have fostered innovative research projects, enabling shared knowledge and the development of groundbreaking solutions to combat influenza viruses.

Conclusion

In conclusion, Masatoshi Oshita's contributions to the scientific community through his patents on human anti-human influenza virus antibodies highlight his role as a leading innovator in immunology. His work not only enhances therapeutic approaches to influenza but also underlines the importance of collaborative research in the pursuit of medical advancements. As the fight against viral infections continues, Oshita's research remains an essential component of the ongoing quest for effective treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…